Key Takeaways
- Arizona dental owners face a critical choice between DSO affiliation and a private-buyer sale, and a structured sell-side framework can support that decision.
- The seven-step process starts with clarifying personal goals and readiness, then assembling an advisory team and gathering financial documentation.
- A diligence-grade, side-by-side valuation can show the real market value difference between DSO and private-buyer pathways.
- Running a competitive process with multiple qualified buyers can create leverage to negotiate price and terms while reviewing clinical autonomy and equity rollover options.
- McLerran & Associates provides Arizona owners with sell-side representation that compares both transition paths objectively. Schedule a free, confidential discovery call to explore which path can align with your goals.
Key Terms and Today’s Dental Deal Landscape
Arizona owners benefit from a shared vocabulary before they review any offer. The terms below appear in most DSO and private-buyer transactions.
- EBITDA – Earnings Before Interest, Taxes, Depreciation, and Amortization. DSOs and private equity buyers use this profitability metric to value larger practices. It removes financing costs and non-cash charges to highlight the cash the business can generate.
- SDE (Seller’s Discretionary Earnings) – A broader earnings figure used for smaller, owner-operated practices. It adds back the owner’s compensation and personal expenses on top of EBITDA, so it reflects what a single working owner can take home.
- Valuation – The estimated market value of the practice. It is usually expressed as a multiple of EBITDA or SDE, or as a percentage of annual collections.
- Letter of Intent (LOI) – A mostly non-binding term sheet that outlines the proposed purchase price, deal structure, exclusivity period (typically 30 to 90 days), and key conditions before attorneys draft a formal purchase agreement.
- Due Diligence (Diligence) – The buyer’s formal review of the practice’s financials, operations, legal standing, and patient base after the LOI is signed.
- DSO (Dental Service Organization) – A management company that acquires the non-clinical assets of a dental practice and provides administrative services, such as HR, billing, marketing, and procurement, under a Management Services Agreement (MSA). The dentist keeps the licensed professional corporation.
- Private Buyer – An individual dentist who purchases the practice in a doctor-to-doctor transaction, usually with SBA financing.
- Earnout – A portion of the purchase price paid after closing if the practice meets agreed production or EBITDA targets during a set period, commonly 12 to 36 months.
- Equity Rollover – The portion of sale proceeds the seller receives as ownership shares in the DSO platform instead of cash. Equity rollover in DSO transactions typically ranges from 15% to 40% of total consideration, which can create a second payout if the DSO platform is later sold or recapitalized.
- Recapitalization (Recap) – A transaction where a private equity firm sells the DSO platform to a new, larger investor, often at a higher multiple. Equity-holding dentists can receive a second payout at that point.
- Transition Timeline – The full arc from initial valuation to closed deal. A typical confidential dental practice sale process runs 6 to 12 months from valuation or engagement to close, though some deals close in 5-9 months.
The U.S. dental market now splits meaningfully between two buyer types. Approximately 120–160 dental deals or practice acquisitions occur annually involving PE-backed DSOs. DSO buyers can represent a substantial share of total dental transaction volume in active years. Private buyers, usually individual dentists using SBA loans, remain the dominant path for smaller, solo-doctor practices. The right path for any Arizona owner can depend on practice size, specialty, profitability, and personal goals, not on which buyer calls first. That is why this framework starts with internal clarity before any external conversations.
Step 1: Clarify Your Goals and Timing Readiness
The first action is internal goal setting. The owner can define a clear “why,” such as reducing the burden of running the business, taking chips off the table while continuing to practice, planning a full exit within a set horizon, or protecting staff and patients through a structured succession.
These answers shape every later decision. An owner who wants to exit fully within 2 years faces a different set of viable structures than an owner who plans to remain clinically active for a decade. Because these goals affect the household and any partners, stakeholders at this stage often include the owner, their spouse or financial planner, and any partners in a group practice. Once goals are aligned among these stakeholders, the main trade-off becomes speed versus optionality. Moving quickly can narrow the buyer pool and compress competitive tension, while taking time to prepare can increase both price and fit.
Step 2: Build Your Advisory Team and Prepare Financials
A dental practice sale usually benefits from a coordinated team. The core group often includes a dental-specific sell-side advisor, a CPA who understands dental transactions, and a dental transaction attorney. The advisor runs the process and shapes the story around value. The CPA handles tax structure and financial preparation. The attorney negotiates the purchase agreement and employment terms.
Financial preparation at this stage involves pulling 3 to 5 years of tax returns, profit-and-loss statements, production-by-provider reports, hygiene reports, accounts receivable aging, payer mix data, and active-patient counts. These documents serve different purposes depending on the chosen path. For the DSO path, the advisor can use these inputs to build a normalized EBITDA analysis, identifying and documenting each add-back, which is a personal or non-recurring expense that inflates costs but would not exist under new ownership. This work can help make the profitability number defensible under buyer review. For the private-buyer path, the same data supports an SDE-based valuation and a realistic asking price.
Step 3: Get a Diligence-Grade, Side-by-Side Valuation
Valuation can determine much of the financial outcome before the first offer appears. A “free” valuation from a buyer or generalist broker often anchors expectations in the buyer’s favor. A diligence-grade valuation, built by a CPA-led team with dental-specific experience, aims to produce a number that holds up when buyers review the details and is less likely to be reduced during diligence.
For Arizona owners who could qualify for either path, a side-by-side valuation can be especially useful. It compares what the practice may be worth in the private-buyer market, usually as a percentage of collections or a multiple of SDE, with what it may be worth in the DSO market, usually as a multiple of normalized EBITDA. DSO buyers can sometimes pay a premium over individual buyers for well-located, profitable practices in metros such as Phoenix. The side-by-side comparison can quantify that gap in real dollars so the owner chooses a path with fuller information.
The main trade-off at this step is price versus fit. The highest DSO offer may not be the right offer, and a private buyer who preserves the practice’s culture and staff can represent a better outcome on factors that matter to the owner beyond the headline number. With a defensible valuation in hand, the owner is better positioned to create competition among multiple buyers.
Step 4: Identify Buyer Types and Create Competition
Approaching a single buyer usually weakens the seller’s position. A structured, competitive process, where multiple vetted buyers submit offers at the same time, can create the tension that pushes price higher and terms closer to the seller’s preferences.
Buyer types in the Arizona market can include national DSO platforms, regional and mid-market DSOs, private equity firms seeking platform acquisitions for practices with substantial EBITDA, and individual dentists using SBA financing. Major DSOs maintain significant Arizona operations, and a growing group of mid-market DSOs is pursuing de novo and acquisition opportunities across the Phoenix metro and nearby communities.
A well-run competitive process for a DSO-path practice often spans about 45 to 60 days and can generate around 10 offers from pre-qualified buyers. For a private-buyer process, the timeline is often somewhat shorter, but the same principle applies. More qualified buyers competing for the same practice can support a better outcome than a single negotiation. Poorly run or undercapitalized buyers are usually screened out before they reach the table, not after an LOI is signed.
Schedule a free, confidential discovery call with McLerran & Associates to see how a competitive, auction-like process can be structured for your Arizona practice.
Step 5: Compare Autonomy, Equity Rollover, and Post-Deal Control
Once offers arrive, the focus shifts from headline price to structure and control. Three areas often deserve close attention.
Clinical Autonomy. DSO transactions use an MSO/PC split structure. The dentist-owned Professional Corporation keeps clinical decision-making, and the DSO’s Management Services Organization handles non-clinical functions under an MSA. In practice, the level of autonomy can vary widely by buyer. Many DSOs allow clinicians to keep full autonomy over treatment planning, materials selection, and patient-care decisions. Others use standardized protocols, preferred materials lists, and production expectations that can limit independence. Because verbal assurances about autonomy can weaken after closing, protections for specific clinical preferences, such as materials brands, lab selection, and minimum appointment times, are usually written into the MSA rather than left to post-close discretion.
Equity Rollover. Rollover equity represents a portion of the sale price paid in illiquid stock, not a bonus on top. As noted earlier, the majority of a DSO purchase price is often paid in cash at close, with the remainder structured as performance-based earnouts and rollover equity. Key terms to review can include share class, tag-along rights, drag-along protections with a floor, a put right at a defined multiple after a set number of years, and information rights. The owner is effectively buying stock in the DSO and can review the platform’s profitability, growth path, and private equity backing with the same care used for any investment.
Post-Deal Control. Nearly every DSO transaction requires the selling dentist to sign an employment agreement and stay with the practice for a set period, often 3 to 5 years. That employment agreement usually includes non-compete provisions that can be broad in geographic scope and duration. Sellers can often benefit from negotiating the least restrictive terms possible at the LOI stage, when leverage is highest. If the deal includes an earnout, additional protections become important. Earnout measurement can be based on a defined same-store basis, with no allocation of corporate overhead to the practice P&L, and acceleration on change of control.
Step 6: Model Multi-Year Economics for Each Path
A DSO offer with a high headline number can sometimes produce a lower after-tax outcome than a private-buyer offer once the full structure is modeled over time. Multi-year financial forecasting can show what each path might net the owner over 3, 5, 7, and 10 years. This view can account for cash at close, equity rollover value under conservative recap assumptions, earnout probability, tax treatment, and the baseline of keeping the practice and continuing to take distributions.
A neutral decision framework at this stage often compares at least 3 scenarios side by side. These scenarios can include a private-buyer sale, a DSO affiliation with a cash-heavy structure, and a DSO affiliation with a higher equity rollover component. The owner’s time horizon, risk tolerance, and confidence in the DSO platform’s future performance can influence which scenario appears most favorable. This modeling is usually completed before any LOI is signed, not after. The insights from that analysis can become the negotiating position when the owner sits down to structure the deal.
Step 7: Negotiate, Manage Diligence, and Close
Negotiation typically begins at the LOI stage, where many of the most important structural terms are set. Price, cash-at-close percentage, equity structure, earnout mechanics, employment agreement length, non-compete scope, and indemnification caps are usually addressed here, before the buyer’s attorneys draft the purchase agreement. The LOI’s exclusivity period, described earlier, prevents the owner from soliciting competing offers once it is signed, which makes it helpful to negotiate favorable terms before signing.
During diligence, the buyer’s team reviews each add-back in the EBITDA analysis. A diligence-grade valuation built up front is more likely to hold under this review, while a weaker one can invite attempts to reduce price. The sell-side advisor’s role at this stage often includes defending the agreed value, managing information flow through a virtual data room, and serving as a buffer between the owner and the buyer’s diligence team. Handoff details such as staff notification timing, patient communication, insurance credentialing transfer, and lease assignment are usually planned before closing, not improvised afterward.
Schedule a free, confidential discovery call with McLerran & Associates to see how sell-side representation through each step of this process can help protect your outcome.
Common Obstacles and How to Address Them
Even with a structured framework, several obstacles can affect a dental practice transition at any stage of the seven-step process. Recognizing them early can be one of the most effective ways to reduce risk.
- Valuation gaps. A buyer’s initial offer reflects that buyer’s internal model, not necessarily the practice’s broader market value. The root cause is often an unsupported EBITDA figure. A diligence-grade valuation with documented add-backs completed before going to market can help address this issue.
- Incomplete financials. Missing tax returns, inconsistent production reports, or unreconciled accounts receivable can slow diligence and give buyers reasons to reduce price. Preparing a clean financial package 60 to 90 days before going to market can reduce these delays.
- Buyer-fit concerns. The highest bidder may not be the right cultural or operational fit. Running a competitive process with a vetted buyer pool, instead of accepting the first offer, can allow the owner to focus on both price and fit at the same time.
- Diligence re-trades. Some buyers attempt to reduce the agreed price after the LOI by raising issues during diligence. A well-prepared data room and a sell-side advisor who can defend the EBITDA analysis are common defenses.
- Timing misalignment. An owner who needs to close within a specific window may feel pressure to accept weaker terms. Starting the process 12 to 18 months before the desired close date can preserve more options and support confidentiality planning.
- Confidentiality breaches. Staff or patient awareness of a pending sale before the owner is ready to communicate can destabilize the practice. A structured confidentiality protocol, including staged disclosure and a communication plan, can help protect stability during the process.
- Advisor coordination failures. When the sell-side advisor, CPA, and attorney are not aligned, deals can slow or fall apart. Assembling a coordinated team early and setting clear roles can reduce this risk.
Measuring Success and Tracking Progress
Several objective indicators can signal a well-run transition process.
- Valuation quality: The EBITDA analysis holds up under buyer review without major adjustment.
- Buyer interest: The competitive process attracts multiple qualified offers instead of limited or no response.
- Timeline adherence: The process moves through milestones such as valuation, go-to-market, offer receipt, LOI, diligence, and close on a reasonable schedule.
- Diligence outcomes: The agreed LOI price generally holds through diligence, with limited attempts to re-trade.
- Deal certainty: The buyer has confirmed financing, approval authority, and capacity to integrate the practice.
- Staff retention signals: Key team members remain stable and unaware of the transaction until the planned disclosure date.
- Alignment with owner goals: The selected buyer matches the owner’s stated priorities for clinical autonomy, staff continuity, and legacy.
Simple tracking methods can include a milestone checklist reviewed at each stage, a side-by-side offer comparison matrix updated as bids arrive, and a periodic advisor debrief after each major buyer interaction. Early-stage progress often appears in buyer engagement and offer quality. Final-stage progress often appears in whether the agreed terms survive diligence and the deal closes at the expected value.
Advanced Planning for Future Practice Transitions
The seven-step framework also serves owners who are not yet ready to transact. Arizona owners planning a sale 12 to 36 months out can use this structure as a preparation roadmap. Practices in that window often benefit from steps such as reducing owner dependence, adding or stabilizing associate coverage, strengthening hygiene recall systems, and cleaning up financial reporting so the books are diligence-ready when needed.
For multi-location group owners, the framework applies at the platform level. A group with substantial EBITDA may qualify as a platform acquisition, which is the founding practice of a new DSO, rather than a simple add-on. That status can support different economics. Periodic reassessment of the optimal path, whether private buyer, DSO add-on, or platform, can be useful as revenue and EBITDA cross key thresholds.
Scenario planning can support timing decisions. Owners can model what the practice may be worth today, in 2 years with an added associate, and in 5 years with a second location, instead of reacting only to the first buyer who calls.
Frequently Asked Questions
How long does a dental practice sale typically take in Arizona?
As noted in the foundational terms, the full transition process typically spans 6 to 12 months, though timelines can vary by transaction type and deal complexity. DSO transactions often involve more extensive diligence and can run somewhat longer than private-buyer transactions. Starting the process well before a desired close date can preserve the owner’s ability to run a competitive process without time pressure driving weaker decisions.
What inputs drive the EBITDA valuation for a DSO transaction?
Normalized EBITDA starts with the practice’s reported earnings and then adds back discretionary, personal, and non-recurring expenses that would not continue under new ownership. These items can include above-market owner compensation, personal vehicle expenses, and one-time equipment purchases. The resulting number reflects the cash the practice can generate for a buyer. Payer mix, provider concentration, hygiene revenue as a share of total collections, lease terms, and active-patient count all influence the multiple applied to that EBITDA figure. Practices with high owner dependence, significant Medicaid exposure, or short lease terms can experience lower multiples than otherwise comparable practices.
What happens to staff after a DSO affiliation?
In many DSO transactions, non-clinical staff move to employment under the DSO’s HR framework, which can change payroll systems, benefits, and compensation terms. Clinical staff usually sign new employment agreements as part of the affiliation. Staff retention can be a meaningful driver of post-close performance and earnout outcomes. Negotiating written staff retention commitments into the purchase agreement, and planning a thoughtful communication strategy, can support both the team and the seller’s earnout.
What is the difference between joint-venture equity and holding-company equity in a DSO deal?
Joint-venture equity gives the selling dentist an ownership stake in their specific practice location alongside the DSO, usually with ongoing distributions from that location’s profits. Holding-company equity gives the dentist a stake in the DSO’s parent platform, which typically does not pay current distributions but can offer a larger payout if the platform is sold at a higher multiple in a future recapitalization. The right structure can depend on the owner’s time horizon, risk tolerance, and confidence in the DSO platform’s growth. Both types of equity are usually illiquid until a future exit event.
When does it make sense to delay a sale process?
Delaying can make sense when the practice’s financials are not yet in diligence-ready condition, when a key associate has recently departed and collections are temporarily lower, when a lease renewal is pending that could affect value, or when the owner has not yet clarified post-sale goals. A process that reaches the market before the practice is positioned well can anchor value at a lower number and reduce buyer confidence. A qualified sell-side advisor can review readiness and suggest whether to proceed now or prepare for a stronger process in 12 to 18 months.
Conclusion: Applying the Framework with Local Support
The seven steps described here, from clarifying goals through negotiating and closing, form a practical sell-side framework for Arizona owners who are weighing DSO affiliation against a private-buyer sale. The sequence is intentional, and skipping steps can be one of the ways value is lost.
McLerran & Associates is a dental-specific sell-side advisor that supports both transition paths in roughly equal measure, with about 50% private-buyer transactions and 50% DSO affiliations. This balance can give Arizona owners a side-by-side comparison that single-lane brokers may not provide. The firm’s Phoenix office, led by Brian Carroll and covering the Mountain West, brings that capability to the Arizona market. Each engagement starts with a CPA-led, diligence-grade EBITDA analysis that shapes the story around your profitability from the first conversation through close. From that foundation, McLerran creates a competitive dynamic among a vetted pool of well-qualified buyers so you can pursue stronger pricing and terms than you might achieve negotiating alone. Poorly run or undercapitalized buyers are filtered out before they reach the table.
The firm’s track record across roughly 2,000 successful practice sales, approximately $2 billion in closed transaction volume, and more than 10,000 practices evaluated reflects a consistent approach. The focus remains on finding the right fit, supporting your outcome, and maintaining control of the EBITDA narrative from start to finish.
Schedule a free, confidential discovery call with McLerran & Associates, Phoenix office, Brian Carroll, covering the Mountain West, to discuss your practice, your goals, and which path may be appropriate for you. Call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us.
